Bharat Parenterals shareholders approve FY26 financials, dividend at AGM
- Bharat Parenterals Limited concluded its 33rd AGM on September 19, 2026
- Shareholders approved FY26 audited financial statements and final dividend
- Mr. Hemang Shah was reappointed as Executive Director after retiring by rotation
- All resolutions passed with requisite majority via remote e-voting and AGM voting
- Statutory and secretarial auditor reports were unqualified with no adverse observations

*this image is generated using AI for illustrative purposes only.
Bharat Parenterals Limited concluded its 33rd Annual General Meeting on September 19, 2026. The meeting was held via video conferencing from its registered office in Vadodara, Gujarat.
Members approved the audited financial statements for the fiscal year ended March 31, 2026. The company also declared a final dividend for FY26 during the proceedings.
Key Resolutions Passed
The shareholders passed several ordinary resolutions during the meeting. Key decisions included the reappointment of board members and ratification of auditor fees.
| Resolution Type | Details | Status |
|---|---|---|
| Financial Approval | Adoption of audited financials for FY26 | Passed |
| Dividend Declaration | Final dividend for FY26 | Passed |
| Board Reappointment | Reappointment of Mr. Hemang Shah as Executive Director | Passed |
| Auditor Fees | Ratification of remuneration for M/S. CMA Chetan Gandhi | Passed |
| Related Party Transactions | Approval of related party transactions | Passed |
Mr. Hemang Shah retires by rotation and offered himself for reappointment as Executive Director. Members approved his reappointment. The company also ratified the remuneration payable to M/S. CMA Chetan Gandhi, Cost Accountants, for the financial year ending March 31, 2027.
Meeting Proceedings
Mr. Bharatkumar Desai, Chairman & Managing Director, addressed the members. He provided an overview of the company’s financial performance and future outlook. The statutory auditors’ report dated May 18, 2026, and the secretarial auditors’ report dated August 5, 2026, were unqualified with no adverse observations.
Remote e-voting commenced on September 16, 2026, at 9:00 am and concluded on September 18, 2026, at 5:00 pm. E-voting was also available during the AGM for members present who had not voted remotely. M/S. Jigar Trivedi & Co acted as the scrutinizer for the voting process.
Voting Results Details
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed the details of voting results inclusive of remote e-voting and e-voting in relation to the 33rd Annual General Meeting (AGM) held on Saturday, September 19, 2026.
The meeting commenced at 11:00 am and concluded at 11:30 am through Video Conferencing (VC) / Other Audio Video Means (OAVM). All resolutions were passed with the requisite majority.
| Sr. No | Agenda | Resolution Type | Mode of Voting | Remarks |
|---|---|---|---|---|
| 1 | Adoption of Audited Financial Statements for FY26 | Ordinary | Remote e-voting and voting during the AGM | Passed with requisite majority |
| 2 | Declaration of Final Dividend for FY26 | Ordinary | Remote e-voting and voting during the AGM | Passed with requisite majority |
| 3 | Re-appointment of Mr. Hemang J Shah as Director | Ordinary | Remote e-voting and voting during the AGM | Passed with requisite majority |
| 4 | Re-appointment of Mr. Hemang Shah as Executive Director | Ordinary | Remote e-voting and voting during the AGM | Passed with requisite majority |
| 5 | Ratification of remuneration to M/s. CMA Chetan Gandhi | Ordinary | Remote e-voting and voting during the AGM | Passed with requisite majority |
| 6 | Approval of Related Party Transactions | Ordinary | Remote e-voting and voting during the AGM | Passed with requisite majority |
Mr. Sharmin Soni, Company Secretary & Compliance Officer, confirmed the results. The consolidated report of the Scrutinizer on remote e-voting and e-voting during the AGM was enclosed with the disclosure.
Historical Stock Returns for Bharat Parenterals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.34% | +8.53% | +24.52% | +43.40% | +43.40% | +43.40% |
How does the declared final dividend for FY26 compare to previous years, and what does this signal about the company's cash flow stability?
What specific growth strategies or capacity expansion plans did Chairman Mr. Bharatkumar Desai outline for the upcoming fiscal year?
How might the reappointment of Mr. Hemang Shah as Executive Director influence the company's operational continuity and strategic direction?

































